HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

AuthorsFederico Pea, Piergiorgio Cojutti, Nicola Petrosillo, Mario Furlanut, J M Entenza, T R Veloso, J Vouillamoz, M Giddey, P Moreillon
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 55 Issue 9 Pg. 4496; author reply 4496-7 (Sep 2011) ISSN: 1098-6596 [Electronic] United States
PMID21849572 (Publication Type: Letter, Comment)
Chemical References
  • Anti-Bacterial Agents
  • Vancomycin
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Endocarditis (drug therapy)
  • Staphylococcus aureus (drug effects, pathogenicity)
  • Vancomycin (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: